Immune Checkpoint Inhibitors and Pregnancy: Analysis of the VigiBase(®) Spontaneous Reporting System

SIMPLE SUMMARY: In preclinical studies, it has been shown that the blockade of immune checkpoint pathways increases the risk of fetal death. Therefore, the use of immune checkpoint inhibitors (ICIs) in cancer patients who are either pregnant or of childbearing potential is not recommended. Neverthel...

Descripción completa

Detalles Bibliográficos
Autores principales: Noseda, Roberta, Müller, Laura, Bedussi, Francesca, Fusaroli, Michele, Raschi, Emanuel, Ceschi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818632/
https://www.ncbi.nlm.nih.gov/pubmed/36612168
http://dx.doi.org/10.3390/cancers15010173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818632/
https://www.ncbi.nlm.nih.gov/pubmed/36612168
http://dx.doi.org/10.3390/cancers15010173

Ejemplares similares